{"id":"https://openalex.org/W4384521171","doi":"https://doi.org/10.1080/07391102.2023.2236714","title":"Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study","display_name":"Exploring epigenetic drugs as potential inhibitors of SARS-CoV-2 main protease: a docking and MD simulation study","publication_year":2023,"publication_date":"2023-07-17","ids":{"openalex":"https://openalex.org/W4384521171","doi":"https://doi.org/10.1080/07391102.2023.2236714","pmid":"https://pubmed.ncbi.nlm.nih.gov/37458994"},"language":"en","primary_location":{"id":"doi:10.1080/07391102.2023.2236714","doi":"https://doi.org/10.1080/07391102.2023.2236714","is_oa":false,"landing_page_url":"https://doi.org/10.1080/07391102.2023.2236714","pdf_url":null,"source":{"id":"https://openalex.org/S178711970","display_name":"Journal of Biomolecular Structure and Dynamics","issn_l":"0739-1102","issn":["0739-1102","1538-0254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biomolecular Structure and Dynamics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Exploring_epigenetic_drugs_as_potential_inhibitors_of_SARS-CoV-2_main_protease_a_docking_and_MD_simulation_study/23696360","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011896955","display_name":"U\u011fur Uzuner","orcid":"https://orcid.org/0000-0002-5308-3730","observed_orcids":["https://orcid.org/0000-0002-5308-3730"]},"institutions":[{"id":"https://openalex.org/I162720556","display_name":"Karadeniz Technical University","ror":"https://ror.org/03z8fyr40","country_code":"TR","type":"education","lineage":["https://openalex.org/I162720556"]},{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["TR","US"],"is_corresponding":true,"raw_author_name":"Ugur Uzuner","raw_affiliation_strings":["Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey","Synthetic and Systems Biology Innovation Hub, Texas A&M University, College Station, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey","institution_ids":["https://openalex.org/I162720556"]},{"raw_affiliation_string":"Synthetic and Systems Biology Innovation Hub, Texas A&M University, College Station, TX, USA","institution_ids":["https://openalex.org/I91045830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063161838","display_name":"Ebru Akkus","orcid":"https://orcid.org/0000-0002-3940-0955","observed_orcids":["https://orcid.org/0000-0002-3940-0955"]},"institutions":[{"id":"https://openalex.org/I109297418","display_name":"Gebze Technical University","ror":"https://ror.org/01sdnnq10","country_code":"TR","type":"education","lineage":["https://openalex.org/I109297418"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Ebru Akkus","raw_affiliation_strings":["Department of Bioengineering, Faculty of Science, Gebze Technical University, Kocaeli, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Bioengineering, Faculty of Science, Gebze Technical University, Kocaeli, Turkey","institution_ids":["https://openalex.org/I109297418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035962182","display_name":"Abdulkad\u0131r Kocak","orcid":"https://orcid.org/0000-0001-6891-6929","observed_orcids":["https://orcid.org/0000-0001-6891-6929"]},"institutions":[{"id":"https://openalex.org/I109297418","display_name":"Gebze Technical University","ror":"https://ror.org/01sdnnq10","country_code":"TR","type":"education","lineage":["https://openalex.org/I109297418"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Abdulkadir Kocak","raw_affiliation_strings":["Department of Chemistry, Faculty of Science, Gebze Technical University, Kocaeli, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, Faculty of Science, Gebze Technical University, Kocaeli, Turkey","institution_ids":["https://openalex.org/I109297418"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077404242","display_name":"Selcen \u00c7elik Uzuner","orcid":"https://orcid.org/0000-0002-9558-7048","observed_orcids":["https://orcid.org/0000-0002-9558-7048"]},"institutions":[{"id":"https://openalex.org/I162720556","display_name":"Karadeniz Technical University","ror":"https://ror.org/03z8fyr40","country_code":"TR","type":"education","lineage":["https://openalex.org/I162720556"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Selcen \u00c7elik Uzuner","raw_affiliation_strings":["Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology and Genetics, Faculty of Science, Karadeniz Technical University, Trabzon, Turkey","institution_ids":["https://openalex.org/I162720556"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5011896955","https://openalex.org/A5077404242"],"corresponding_institution_ids":["https://openalex.org/I162720556","https://openalex.org/I91045830"],"apc_list":null,"apc_paid":null,"fwci":0.3481,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.45947122,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"42","issue":"13","first_page":"6892","last_page":"6903"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.864300012588501,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.864300012588501,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.11840000003576279,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/main-protease","display_name":"main protease","score":0.9580000042915344},{"id":"https://openalex.org/keywords/mpro-inhibitors","display_name":"Mpro inhibitors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/epigenetic-drugs","display_name":"epigenetic drugs","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.7799999713897705},{"id":"https://openalex.org/keywords/guadecitabine","display_name":"guadecitabine","score":0.9200000166893005},{"id":"https://openalex.org/keywords/histone-methyltransferase-inhibitors","display_name":"histone methyltransferase inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nirmatrelvir","display_name":"nirmatrelvir","score":0.953000009059906},{"id":"https://openalex.org/keywords/binding-affinity","display_name":"binding affinity","score":0.6140000224113464},{"id":"https://openalex.org/keywords/binding-free-energy","display_name":"binding free energy","score":0.7289999723434448},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.8949999809265137}],"concepts":[{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.5746868848800659},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5250341892242432},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4920656085014343},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47599589824676514},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.46253541111946106},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45490819215774536},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.45029374957084656},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.43746793270111084},{"id":"https://openalex.org/C103697762","wikidata":"https://www.wikidata.org/wiki/Q4112105","display_name":"Virtual screening","level":3,"score":0.4114249050617218},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.41122978925704956},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.4033198952674866},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.3598572015762329},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3054201006889343},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.28706446290016174},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2788486182689667},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21479353308677673},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.14913558959960938},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1365635097026825},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.11188066005706787},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D000086782","descriptor_name":"Coronavirus 3C Proteases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000086782","descriptor_name":"Coronavirus 3C Proteases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000086782","descriptor_name":"Coronavirus 3C Proteases","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000093485","descriptor_name":"COVID-19 Drug Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007769","descriptor_name":"Lactams","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007930","descriptor_name":"Leucine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011392","descriptor_name":"Proline","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013816","descriptor_name":"Thermodynamics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D044127","descriptor_name":"Epigenesis, Genetic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1080/07391102.2023.2236714","doi":"https://doi.org/10.1080/07391102.2023.2236714","is_oa":false,"landing_page_url":"https://doi.org/10.1080/07391102.2023.2236714","pdf_url":null,"source":{"id":"https://openalex.org/S178711970","display_name":"Journal of Biomolecular Structure and Dynamics","issn_l":"0739-1102","issn":["0739-1102","1538-0254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Biomolecular Structure and Dynamics","raw_type":"journal-article"},{"id":"pmid:37458994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37458994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of biomolecular structure & dynamics","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/23696360","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Exploring_epigenetic_drugs_as_potential_inhibitors_of_SARS-CoV-2_main_protease_a_docking_and_MD_simulation_study/23696360","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.23696360.v1","doi":"https://doi.org/10.6084/m9.figshare.23696360.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.23696360.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/23696360","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Exploring_epigenetic_drugs_as_potential_inhibitors_of_SARS-CoV-2_main_protease_a_docking_and_MD_simulation_study/23696360","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":70,"referenced_works":["https://openalex.org/W1573009101","https://openalex.org/W1970973025","https://openalex.org/W1978330227","https://openalex.org/W2006500779","https://openalex.org/W2007757039","https://openalex.org/W2024762727","https://openalex.org/W2043509228","https://openalex.org/W2047730466","https://openalex.org/W2063206968","https://openalex.org/W2067970470","https://openalex.org/W2117247812","https://openalex.org/W2140151763","https://openalex.org/W2161605421","https://openalex.org/W2169678694","https://openalex.org/W2170146596","https://openalex.org/W2271364972","https://openalex.org/W2327581403","https://openalex.org/W2330799739","https://openalex.org/W2345649975","https://openalex.org/W2388080941","https://openalex.org/W2593436234","https://openalex.org/W2595282501","https://openalex.org/W2718878673","https://openalex.org/W2749527778","https://openalex.org/W2783681880","https://openalex.org/W2797292560","https://openalex.org/W2800221771","https://openalex.org/W2801540524","https://openalex.org/W2906582279","https://openalex.org/W2955341169","https://openalex.org/W2990651115","https://openalex.org/W3006973065","https://openalex.org/W3007086572","https://openalex.org/W3011467845","https://openalex.org/W3015608194","https://openalex.org/W3015741518","https://openalex.org/W3020300207","https://openalex.org/W3026020920","https://openalex.org/W3027630905","https://openalex.org/W3032997187","https://openalex.org/W3040116040","https://openalex.org/W3080517202","https://openalex.org/W3087156149","https://openalex.org/W3092484545","https://openalex.org/W3092951667","https://openalex.org/W3093534666","https://openalex.org/W3097145107","https://openalex.org/W3108064991","https://openalex.org/W3118816970","https://openalex.org/W3124142499","https://openalex.org/W3125614524","https://openalex.org/W3130155181","https://openalex.org/W3137743208","https://openalex.org/W3141730727","https://openalex.org/W3160460047","https://openalex.org/W3192181512","https://openalex.org/W3199358093","https://openalex.org/W3211463067","https://openalex.org/W3214271933","https://openalex.org/W3217441241","https://openalex.org/W4200300989","https://openalex.org/W4206367754","https://openalex.org/W4210866043","https://openalex.org/W4226023710","https://openalex.org/W4280559774","https://openalex.org/W4281752931","https://openalex.org/W4292060935","https://openalex.org/W4319983518","https://openalex.org/W4380201174","https://openalex.org/W6968486756"],"related_works":["https://openalex.org/W6958540278","https://openalex.org/W4281946586","https://openalex.org/W3099685261","https://openalex.org/W4236319046","https://openalex.org/W3044169393","https://openalex.org/W4313362220","https://openalex.org/W3046759714","https://openalex.org/W4312934091","https://openalex.org/W4303198934","https://openalex.org/W3112594448"],"abstract_inverted_index":{"The":[0,97,219],"COVID-19":[1],"pandemic":[2],"has":[3],"caused":[4],"havoc":[5],"around":[6],"the":[7,14,19,23,57,66,69,104,113,159,180,183,202,206],"globe":[8],"since":[9],"2019":[10],"and":[11,124,151,175],"is":[12],"considered":[13],"largest":[15],"global":[16],"epidemic":[17],"of":[18,73,107,182,205,229],"twentieth":[20],"century.":[21],"Although":[22],"first":[24,67,114],"antiviral":[25,203,227],"drug,":[26],"Remdesivir,":[27],"was":[28,49,110],"initially":[29],"introduced":[30],"against":[31,56,78],"COVID\u201119,":[32],"virtually":[33],"no":[34],"tangible":[35],"therapeutic":[36],"drugs":[37,76],"exist":[38],"to":[39,85,93,138,142,196],"treat":[40],"SARS-CoV-2":[41,58,79,108,139,165],"infection.":[42],"FDA-approved":[43],"Paxlovid":[44],"(Nirmatrelvir":[45],"supplemented":[46],"by":[47,116,241],"Ritonavir)":[48],"recently":[50],"announced":[51],"as":[52,158,224],"a":[53],"promising":[54,83,161],"drug":[55],"major":[59],"protease":[60],"(Mpro).":[61],"Here":[62],"we":[63],"report":[64],"for":[65,99,103,112,164,232],"time":[68,115],"remarkable":[70],"inhibitory":[71],"potentials":[72],"lead":[74],"epigenetic-targeting":[75],"(epi-drugs)":[77],"Mpro.":[80,166],"Epi-drugs":[81],"are":[82,209],"compounds":[84],"be":[86],"used":[87],"in":[88,214,234],"combination":[89,215],"with":[90,133,186,216,237],"cancer":[91],"chemotherapeutics":[92],"regulate":[94],"gene":[95],"expression.":[96],"search":[98],"all":[100],"known":[101],"epi-drugs":[102,130,208,230],"specific":[105],"inhibition":[106],"Mpro":[109,140],"performed":[111],"consensus":[117],"(three":[118],"high-order":[119],"program)":[120],"molecular":[121],"docking":[122],"studies":[123],"end-state":[125],"free":[126,189],"energy":[127,190],"calculations.":[128],"Several":[129],"were":[131,156],"identified":[132],"highly":[134],"comparable":[135],"binding":[136,188],"affinity":[137],"compared":[141,195],"Nirmatrelvir.":[143],"In":[144],"particular,":[145],"potent":[146],"histone":[147],"methyltransferase":[148,153],"inhibitor":[149,154],"EPZ005687":[150],"DNA":[152],"Guadecitabine":[155],"prominent":[157],"most":[160],"epi-drug":[162],"inhibitors":[163],"Long":[167],"Molecular":[168],"dynamics":[169],"(MD)":[170],"simulations":[171],"(200":[172],"ns":[173],"each)":[174],"corresponding":[176],"MM-GBSA":[177,187],"calculations":[178],"confirmed":[179],"stability":[181],"EPZ005687-Mpro":[184],"complex":[185],"(\u0394Gbind)":[191],"\u221248.2":[192],"kcal/mol":[193],"(EPZ005687)":[194],"Nirmatrelvir":[197],"(\u201344.7":[198],"kcal/mol).":[199],"Taken":[200],"together,":[201],"activities":[204],"highlighted":[207],"reported":[210],"beyond":[211],"widespread":[212],"use":[213,233],"anti-cancer":[217],"agents.":[218],"current":[220],"findings":[221],"therefore":[222],"highlight":[223],"yet":[225],"unexplored":[226],"potential":[228],"suitable":[231],"patients":[235],"struggling":[236],"chronic":[238],"immunosuppressive":[239],"disorders.Communicated":[240],"Ramaswamy":[242],"H.":[243],"Sarma":[244]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2023-07-18T00:00:00"}